Q23AS2 AF NFT

Tubulin glycylase 3E

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibkt5vnqsqloc4pclb6pn72oyqeoqqtfbfcd3zg7jnapmhn6srwbi/metadata.json
IPFS of structure file: 
bafybeielvmks2okizsaqma2qt7yltx7qgcuv657xx6tmf554je3wghmqe4/AF-Q23AS2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x520AB67aC243f53328F015981f71b4911C1030B0
First NFT owner address (bech32): 
genesis12g9tv7kzg06nx28szkvp7ud5jywpqv9scf6eyt
Current NFT ID #481872 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
481872
Accession (UniProt):
Q23AS2
Name::
Tubulin glycylase 3E
Experimental Method:
Predicted structure
Sequence source:
TETRAHYMENA THERMOPHILA (STRAIN SB210)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q23AS2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q23AS2|TTL3E_TETTS Tubulin glycylase 3E OS=Tetrahymena thermophila (strain SB210) OX=312017 GN=TTLL3E PE=3 SV=1 MILPFEYYFLNDADNSSKSNYNNIQFINENQNNNLRQKPKFYPNNQFLIEQEQDKYENKKIKNYISDQIQLQPKNTPINKMNHFANINNYQDNKFSLESLNQAQQDNLQKEEDLSILSFDSQEELNYLQEGEENNQFLNEGDIFGYQTRYTFFENRNNLLVEDATNKNNNNYNYNYNNNNSSTQRNYDFNYQNTNEMLQKKKKSNFQNKSQSQLNNHKNEEKKPSQQRKEQLMKRFESLSRIYNKELSQTVTNGWLKPSQAKTISQDNNLGSSAAKSSKVFYQQQKPFSAQITNSSLKYAAASNGFQNLDFSYKQKQQLIQQETKNKIKEQQNVESNNRISMKPPKSANLNSYKNISNLKNFKEIILTRPNSKQVKFQQQNSVNSQPSSLVSQPLKIQSIEKNNLNSNLNDQNFYDDFAELGSTETTGFSFQNVFQLAGVPKDFIASPRSPVQELNQKQENRENELDQMLNDHHIYVASSVTNQNQIKNEQTERKPNMFGKTLTTLARPFSKEYSNRKDILKSAQQNVRFNKNLDYLDSQNKVVAKNKKRTIFKINQNNLQGNQKDLQSNQTSSVISQQNSIQQYGDDNYQQNQVLNDDQSPLIKQNSIDLNAAEIIQNDENENTQKENVLQQKKNQSNQIVTSQQQSNNYFKQETTTNTSNFSTTSNRIISLQALRQKNNSTVKNSDNNNQNQTNPQNQNTNLKENNDKQNLKKTKIQSASANQAGQSNNQLQKTFFINSQDEYVRRTLLRMGWKENKLLLNNNFDLKWIYIDSNDDYKFLNDNQFYNHFKNNTELTQKGRLLYNLKNNTQFGVNQELFFPRCYDLGNDQERGEFSNEFNRMNVMNLLKKHIQYIKLRRSQTYQEIKQAYQQKQANKLNAQVKDGIFFAKVTKQKFFSPLMYEDTKRDNRFIFNITVIAEAVEILKKLKRQQEEYIDETRQSRDCQLYIYQTNFKLESMISQYVKINVPFDEEKFVFEKIVGMSKEHWSSPSMKLMKKLYSLYKYFKDADPQFKVSGTKNIWIIKPSANSRGSGIYLVDKLDEAIDSGLKMQARIVQKYIERPLIFQGAKYKKLNNKKFDIRQWVLVTSFKPLKIYFFTSSYLRVCSQSFDLDNIKILSKHLTNFSLNKNSLAKENWDETVVELKDFISYLKEFKNIDYQEDVKPKIKDLVIETIKCAADKIVNRKKSFELYGFDILLDEYAHPWLLEVNLSPACSERSSFLTEMLDAMAYKMFQIVFKQNNLQEDLEINKETAISTAPASCQNPDYDWEEIYNEEQKEYFCEEDNNMQLAFNNDIQLMVIGQKADLKKEKNLDKKYFQYWGAIKIQSKIRSFLAKKKLQRLKNQKFTFAAIKIQQKMRQFLAKKQLNILKKQQQTNINIPIEDFNQVSVIEV